Morgan Stanley analyst Meta Marshall upgraded Viavi (VIAV) to Equal Weight from Underweight with a price target of $11, up from $9.30, also discontinuing the firm’s coverage of the stock. The catalyst path that the company’s pending acquisition of the Spirent asset offers Viavi with significant presence in the critical channel emulation market, providing growth opportunities in key technology testing markets and potential accretion, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VIAV:
- Balanced Outlook on Viavi Solutions Amid Acquisition Prospects and Market Challenges
- Viavi Solutions Issues $250M Convertible Notes
- Viavi Solutions Announces $250M Convertible Notes Issuance
- Viavi Solutions Faces Acquisition Challenges: Potential Risks and Financial Implications
- Viavi Solutions Inc. Reports Strong Earnings Growth